ArriVent BioPharma, Inc.
USD35.26
+0.89 (+2.59%)
CEO
Zhengbin Yao
IPO Date
2024-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$35.05
Prev. Close
$34.37
Day Low
$34.53
Day High
$35.33
52W Low
$16.10
52W High
$35.83
Market Cap
$1.64B
Volume
0.20M
| -10.4 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -45.8% | -42.5% | 0.00 | 13.76 | -9.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -21.2% | -20.2% | 0.00 | 21.84 | -18.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -125.2% | -119.9% | 0.00 | 23.63 | -0.5 |
| -5.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -11.5% | -10.7% | 0.00 | 14.90 | -5.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -12.6% | -11.7% | 0.00 | 12.74 | -6.1 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -31.8% | -29.9% | 0.00 | 14.34 | -2.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -8.0% | -7.5% | 0.00 | 13.14 | -10.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -7.4% | -7.0% | 0.00 | 19.28 | -9.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -7.4% | -7.1% | 0.00 | 25.50 | -7.0 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -5.5% | -5.3% | 0.00 | 32.82 | -8.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -14.0% | -13.0% | 0.00 | 13.76 | -7.9 |